Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.
Follow-Up Questions
Quel est le ratio P/E de Poniard Pharmaceuticals Inc (PARD) ?
Le ratio P/E de Poniard Pharmaceuticals Inc est de 0
Quelle est la performance du prix de l'action PARD ?
Le prix actuel de PARD est de $0.0001, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Poniard Pharmaceuticals Inc ?
Poniard Pharmaceuticals Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Poniard Pharmaceuticals Inc ?
La capitalisation boursière actuelle de Poniard Pharmaceuticals Inc est de $150
